3 unchanged sentences
Issuer Purchases of Equity Securities
−Removed: The table below sets forth information regarding repurchases of our common stock by us during the three months ended December 31, 2023:
−Removed: Period Total Number of Shares Purchased (1)
−Removed: Average Price Paid per Share Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (2)
−Removed: October 2, 2023 - October 29, 2023 3,674 $ 66.64 — $ 225,677,460
−Removed: October 30, 2023 - November 26, 2023 121,783 60.28 120,000 218,444,460
−Removed: November 27, 2023 - December 31, 2023 858 70.68 — 218,444,460
−Removed: Total 126,315 $ 60.54 120,000 $ 218,444,460
−Removed: (1) Includes shares surrendered, if any, to the Company to satisfy the payment of minimum tax withholding obligations.
−Removed: (2) On August 17, 2022, the Board authorized a stock repurchase program, allowing the Company to repurchase up to $300.0 million of its common stock through August 17, 2024 (the “Stock Repurchase Program”).
−Removed: During the three months ended December 31, 2023, the Company repurchased 120,000 shares of outstanding common stock under the Stock Repurchase Program for approximately $7.2 million.
+Added: On August 17, 2022, our Board authorized the Stock Repurchase Program, allowing us to repurchase up to $300.0 million of our common stock, which expired on August 17, 2024.
+Added: We did not repurchase any shares of our common stock in 2024 through the expiration date.
STOCKHOLDER RETURN PERFORMANCE GRAPH
1 unchanged sentence
The graph assumes (i) an initial investment of $100 as of the market close on December 31, 2019 in our common stock, the Nasdaq Composite Index and the Nasdaq Health Care Composite Index and (ii) reinvestment of dividends.
−Removed: The graph represents stock price performance of Quidel, from fiscal year 2019 through May 27, 2022, and QuidelOrtho following the closing date of the Combinations.
+Added: The graph represents stock price performance of Quidel, from fiscal year ended 2020 through May 27, 2022, and QuidelOrtho following the closing date of the Combinations.
The stock price performance of our common stock depicted in the graph represents past performance only and is not necessarily indicative of future performance.
6 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.